Continuous Monitoring and Control of Hypoglycemia

The study comprises recruitment and consenting of pediatric and adult participants. At entry,
the following information will be collected: demographics, labs, clinical and diabetes
history information (history of mild/severe hypoglycemia or DKA events in the past 6 months
and SMBG testing frequency). There are 3 clinic visits: Study Entry, Month 6 and Month 12 .
Monthly phone contacts will be made to assess for any mild/severe hypoglycemic or DKA events
and any details surrounding an event. Clinic visits at Months 6 and 12 will capture frequency
of SMBG testing, A1C level and PRO information. CGM data will be obtained during the study to
assess for CGM adherence.

Inclusion Criteria:

- Naïve to real-time CGM

- Type 1 or insulin-requiring Type 2 diabetes

- ≥ 2 years old

Exclusion Criteria:

- Use of RT-CGM, within the past 12 months

- Pregnancy

- Concomitant disease or condition that may compromise patient safety including and not
limited to severe mental illness, a diagnosed or suspected eating disorder or any
uncontrolled long term medical condition that would interfere with study related tasks
or visits, or ongoing treatment for a significant malignancy.

- Known (or suspected) significant allergy to medical grade adhesives

- Dialysis